Cedars-Sinai Uses AI to Identify People With Abnormal Heart Rhythms

Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms.

Cleveland Clinic Study Shows Deep Brain Stimulation Encouraging for Stroke Patients

A first-in-human trial of deep brain stimulation (DBS) for post-stroke rehabilitation patients by Cleveland Clinic researchers has shown that using DBS to target the dentate nucleus – which regulates fine-control of voluntary movements, cognition, language, and sensory functions in the brain – is safe and feasible.

‘Carb’ Treatment for Stroke Receives New U.S. Patent

A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Called “Carb” for short, this new formulation is designed to treat ischemic stroke, protect brain tissue against injury and minimize the size of a brain infarct.

Chula’s AICute Innovation – An Assessment Tool for Ischemic Stroke Risk to Reduce Disability and Death

A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chances of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effectiveness of stroke treatment, reduce congestion in hospitals and medical schools.

Stroke Treatment, not Neuroimaging, Drives Stroke Hospital Cost Growth

A study by the Neiman Health Policy Institute found that the costs of an Ischemic Stroke episode increased 4.9% from 2012 to 2019. However, the main driver of those costs was changes in treatments, such as endovascular thrombectomy and intravenous thrombolysis; increases in various types of neuroimaging were not key cost drivers. Over the study period, the share of episodes with treatment increased 155% from 7.3% to 18.5%. There were increases of 80% and 476% in the number of episodes with IVT-only or EVT.

Patients treated by mobile stroke units had better outcomes according to results published in NEJM

Ischemic stroke patients treated on a mobile stroke unit (MSU) received anti-clot medication faster and ended up with less disability at 90 days, according to a study published today in the New England Journal of Medicine led by researchers at UTHealth Houston and Memorial Hermann-Texas Medical Center.

Family of proteins offers promise as ischemic stroke treatment, preclinical trial finds

Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston (UTHealth).

Diet High in Healthful Plant-Based Food May Reduce Risk of Stroke by 10% Diet High in Healthful Plant-Based Food May Reduce Risk of Stroke by 10%

Eating a healthy, plant-based diet that includes foods like vegetables, whole grains and beans, and decreasing intakes of less healthy foods like refined grains or added sugars may reduce your risk of having a stroke by up to 10%, according to a study published in the March 10, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study found a diet high in quality plant-based foods may reduce your risk of having an ischemic stroke.

Could Arm Squeezes with Blood Pressure Cuffs Help the Brain Recover After Stroke?

People who are given clot-busting drugs after a stroke may recover better if they also are given a therapy called remote ischemic postconditioning, according to a new study published in the October 7, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. Remote ischemic conditioning is when blood flow, and the oxygen it carries, is stopped and then restored repeatedly by blood pressure cuffs worn on the arms.

Study Reveals New Way to Treat Stroke Using an Already FDA-Approved Drug

Granulocyte colony-stimulating factor (GCSF) is currently used to treat neutropenia due to chemotherapy and has been successfully used for patients who require bone marrow transplants. The study is the first to report on the neuroprotective effect of GCSF in vivo and showed that it improved neurological deficits that occur in the first few days following cerebral ischemia. GCSF improved long-term behavioral outcomes while also stimulating a neural progenitor recovery response in a mouse model.